≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Motor disorders, excluding more controls

Endpoint Browser PheWeb

KRA_PSY_MOTOR_EXMORE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F82
  • Hospital discharge: ICD-9 — 3154A
  • Cause of death: ICD-10 — F82
  • Cause of death: ICD-9 — 3154A

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F80-F89
Name in latin
Perturbatio specifica progressus functionis motoricae

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 19285 5193 14091
Only index persons 14350 3746 10604
Unadjusted period prevalence (%)
Whole population 0.33 0.15 0.39
Only index persons 0.34 0.14 0.40
Median age at first event (years)
Whole population 5.64 5.23 5.79
Only index persons 6.01 5.73 6.11

-FinnGen-

Key figures

All Female Male
Number of individuals 612 255 357
Unadjusted period prevalence (%) 0.13 0.09 0.16
Median age at first event (years) 6.12 6.05 6.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
539
Matched controls
5187
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F82
ICD-10 Finland
Specific developmental disorder of motor function
9844.3
323.0
504
5
F83
ICD-10 Finland
Mixed specific developmental disorders
1812.6
149.4
140
*
Z2445
NOMESCO Finland
Psychologist
25.3
115.7
169
92
F80.1
ICD-10 Finland
Expressive language disorder
309.1
104.3
104
*
XA800
NOMESCO Finland
Neuropsychological investigation
28.7
103.2
144
65
R62.0
ICD-10 Finland
Delayed milestone
36.8
97.6
127
43
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
13.3
91.6
174
179
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
16.5
81.4
138
106
F90.0
ICD-10 Finland
Disturbance of activity and attention
20.6
80.2
124
74
N05AH04
ATC
quetiapine; oral
21.8
75.4
114
63
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
33.6
73.9
98
34
Z3226
NOMESCO Finland
Physiotherapist
6.6
73.6
233
535
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
72.6
69
*
F80.2
ICD-10 Finland
Receptive language disorder
270.1
72.2
73
*
R4120
NOMESCO Finland
Occupational therapy
18.4
69.7
112
73
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
9.4
69.0
158
220
N05AX08
ATC
risperidone; systemic
248.9
66.9
68
*
N05AH03
ATC
olanzapine; systemic
364.7
66.1
66
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
128.7
65.6
70
6
ZY010
NOMESCO Finland
Hospital outpatient
15.6
62.5
107
81
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
9.4
62.0
140
187
Z2446
NOMESCO Finland
Social worker
7.5
61.6
164
285
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
224.1
60.5
62
*
Z2221
NOMESCO Finland
Medical doctor
5.4
57.2
214
568
Z3231
NOMESCO Finland
Registered nurse
4.6
57.2
272
932
N05AX12
ATC
aripiprazole; systemic
597.5
56.9
56
*
R4110
NOMESCO Finland
Physiotherapy
5.3
55.7
211
565
F29
ICD-10 Finland
Unspecified nonorganic psychosis
561.8
53.7
53
*
N06BA04
ATC
methylphenidate; oral
19.7
52.3
81
46
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
+∞
51.2
49
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
20.8
49.4
75
40
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
10.7
46.6
95
102
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.5
46.0
90
89
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
129.3
45.9
49
*
ZXE10
NOMESCO Finland
More than one and less than three hours
4.2
45.6
227
770
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.9
43.5
167
435
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
11.0
42.6
85
87
RT150
NOMESCO Finland
NA
94.3
40.8
45
5
F93.89
ICD-10 Finland
Other childhood emotional disorders
213.0
39.8
41
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
109.3
38.7
42
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
35.2
38.5
50
15
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
19.8
38.5
59
32
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
38.5
37
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
17.3
37.9
61
38
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
8.6
37.8
87
114
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.0
37.3
184
597
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
9.5
37.3
80
93
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
72.7
36.9
42
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.9
36.9
99
164
ZXD10
NOMESCO Finland
Scheduled procedure
3.4
36.8
248
1034
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
10.5
36.1
73
76
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
190.7
35.7
37
*
N03AX09
ATC
lamotrigine; oral
49.8
35.6
43
9
Z3229
NOMESCO Finland
Other healthcare associate professional
5.8
35.3
110
221
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
14.6
34.9
60
44
RL140
NOMESCO Finland
NA
67.2
33.9
39
6
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
345.3
33.8
34
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
26.7
33.1
46
18
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
334.3
32.8
33
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.1
32.2
148
443
R1260
NOMESCO Finland
Evaluation of communicative skills
63.5
31.9
37
6
Z50.5
ICD-10 Finland
Speech therapy
8.1
31.7
75
102
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
89.9
31.6
35
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.8
31.4
84
137
F81.0
ICD-10 Finland
Specific reading disorder
71.7
30.7
35
5
ZXE00
NOMESCO Finland
One hour or less
3.0
30.4
256
1204
N06AB03
ATC
fluoxetine; oral
16.1
29.8
49
32
N03AG01
ATC
valproic acid; systemic, rectal
11.7
29.5
56
51
R5599
NOMESCO Finland
Other rehabilitation service
31.0
29.3
39
13
ZXE20
NOMESCO Finland
More than three and less than five hours
4.9
28.7
103
239
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
81.8
28.6
32
*
RT160
NOMESCO Finland
NA
28.0
27.8
38
14
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
284.9
27.6
28
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
6.1
27.5
79
141
Z01.8
ICD-10 Finland
Other specified special examinations
4.0
27.4
126
371
602
Kela drug reimbursment
Children's severe malnutrition
9.1
27.3
59
69
N05AH02
ATC
clozapine; systemic
+∞
26.9
26
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
+∞
26.9
26
*
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
+∞
26.9
26
*
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
63.1
26.8
31
5
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
46.6
26.3
32
7
RL130
NOMESCO Finland
NA
46.6
26.3
32
7
R4130
NOMESCO Finland
Speech therapy
14.8
26.0
44
31
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
25.9
25
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
25.7
112
313
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
73.4
25.6
29
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
8.0
25.6
60
80
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
50.8
25.1
30
6
N06AB10
ATC
escitalopram; oral
4.8
24.9
90
209
F20.9
ICD-10 Finland
Schizophrenia, unspecified
+∞
24.8
24
*
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
58.8
24.8
29
5
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.4
24.7
79
160
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
251.7
24.5
25
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
10.5
24.2
48
48
ZYC01
NOMESCO Finland
Remote contact by phone
9.7
24.1
50
54
IGP01
NOMESCO Finland
Psychiatric family contact
22.4
24.1
35
16
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
56.7
23.8
28
5
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
23.8
23
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
6.8
23.7
62
97
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.7
23.7
87
205
N05AA02
ATC
levomepromazine; systemic
241.2
23.5
24
*
N06AX16
ATC
venlafaxine; oral
9.6
23.1
48
52
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
47.2
23.1
28
6
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
9.2
22.9
49
56
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
6.3
22.4
62
105
R1250
NOMESCO Finland
Evaluation of functional capability
27.7
22.0
30
11
G40.9
ICD-10 Finland
Epilepsy, unspecified
11.1
22.0
42
39
P07.2
ICD-10 Finland
Extreme immaturity
52.4
21.9
26
5
RS222
NOMESCO Finland
NA
21.0
21.0
31
15
F84.5
ICD-10 Finland
Asperger syndrome
60.3
20.7
24
*
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
+∞
20.7
20
*
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
77.0
20.5
23
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
15.1
20.5
34
23
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
20.3
184
852
XF400
NOMESCO Finland
ECG with 12 standard connections
3.1
20.3
125
454
T36
ICD-10 Finland
Poisoning by systemic antibiotics
17.5
19.8
31
18
183
Kela drug reimbursment
Lamotrigin and topiramate
57.6
19.7
23
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
19.7
167
741
N03AX14
ATC
levetiracetam; systemic
13.3
19.5
34
26
Z31.5
ICD-10 Finland
Genetic counselling
4.9
19.2
65
140
RF120
NOMESCO Finland
NA
31.4
19.0
25
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
19.0
120
439
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
+∞
18.6
18
*
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
+∞
18.6
18
*
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
18.6
18
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
5.9
18.5
53
94
N06AB06
ATC
sertraline; oral
6.9
18.5
47
71
H52.2
ICD-10 Finland
Astigmatism
7.2
18.2
45
65
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.8
18.2
53
96
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
44.0
18.0
22
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
18.0
107
374
ZXA00
NOMESCO Finland
Right side
3.3
17.7
98
328
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
16.6
17.6
28
17
IGV01
NOMESCO Finland
Psychiatric network contact
66.4
17.5
20
*
N06AX11
ATC
mirtazapine; oral
4.1
17.5
73
193
N05BA04
ATC
oxazepam; oral
5.5
17.4
53
101
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
9.4
17.4
36
39
F88
ICD-10 Finland
Other disorders of psychological development
63.0
16.6
19
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
63.0
16.6
19
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
+∞
16.5
16
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
16.5
95
325
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.9
16.4
72
199
F41.1
ICD-10 Finland
Generalized anxiety disorder
8.1
16.3
37
47
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
168.6
16.3
17
*
A28
ICPC
Limited function/disability NOS
5.4
16.2
50
97
ZXD20
NOMESCO Finland
Day surgery
4.0
16.1
68
182
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.4
16.0
49
94
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
15.9
81
254
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
18.5
15.8
24
13
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
8.3
15.8
35
43
XX4AW
NOMESCO Finland
NA
8.7
15.7
34
40
H01AC01
ATC
somatropin; parenteral
6.2
15.7
43
72
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
+∞
15.5
15
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
+∞
15.5
15
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
22.0
15.3
22
10
N05CD08
ATC
midazolam; nasal, systemic
7.5
15.2
36
49
N05BA09
ATC
clobazam; oral
14.8
15.1
25
17
IEP99
NOMESCO Finland
Other psychiatric family intervention
44.7
14.9
18
*
RD210
NOMESCO Finland
NA
4.4
14.7
54
127
F99
ICD-10 Finland
Mental disorder, not otherwise specified
56.2
14.6
17
*
K03.66
ICD-10 Finland
Tooth plaque
2.9
14.6
97
364
WX882
NOMESCO Finland
High dependency care
3.4
14.6
76
242
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
18.3
14.5
22
12
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
13.2
14.5
25
19
SPAT1307
SPAT
Psychosocial counselling and guidance
3.2
14.4
82
278
RT490
NOMESCO Finland
NA
79.3
14.4
16
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
148.2
14.3
15
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
35.7
14.3
18
5
ZXA05
NOMESCO Finland
Left side
3.1
13.8
81
278
ZXA10
NOMESCO Finland
Bilateral
2.8
13.8
99
388
R11
ICD-10 Finland
Nausea and vomiting
3.4
13.6
68
210
RS220
NOMESCO Finland
NA
9.1
13.5
28
31
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
74.2
13.4
15
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
13.4
13
*
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
+∞
13.4
13
*
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
138.0
13.3
14
*
L02AE02
ATC
leuprorelin; implant, parenteral
16.1
13.2
21
13
WX730
NOMESCO Finland
Conventional respirator
18.1
13.2
20
11
ZXD05
NOMESCO Finland
Urgent procedure
2.3
13.1
136
654
RS211
NOMESCO Finland
NA
13.7
13.0
22
16
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
39.6
13.0
16
*
N05BA06
ATC
lorazepam; systemic, sublingual
39.6
13.0
16
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.5
12.9
46
105
FM2CE
NOMESCO Finland
NA
3.5
12.8
62
186
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
10.9
12.8
24
22
SPAT1234
SPAT
Support of social functional capacity
10.9
12.8
24
22
EBA15
NOMESCO Finland
Extraction of large number of teeth
8.8
12.8
27
31
F39
ICD-10 Finland
Unspecified mood [affective] disorder
18.9
12.7
19
10
H50.0
ICD-10 Finland
Convergent concomitant strabismus
8.1
12.6
28
35
SPAT1229
SPAT
Assessment of need for aid
10.5
12.5
24
23
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
31.7
12.4
16
5
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
+∞
12.4
12
*
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
12.4
12
*
P72
ICPC
Schizophrenia
+∞
12.4
12
*
RT422
NOMESCO Finland
NA
+∞
12.4
12
*
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
+∞
12.4
12
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.9
12.4
52
139
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
127.9
12.3
13
*
H50.31
ICD-10 Finland
Intermittent exotropia
6.7
12.3
31
47
N05BA01
ATC
diazepam; systemic, rectal
4.4
12.2
45
106
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
13.1
12.2
21
16
WX002
NOMESCO Finland
Sedation and analgesia
3.2
12.2
67
219
RF420
NOMESCO Finland
NA
26.4
11.9
16
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
11.9
61
192
F43.1
ICD-10 Finland
Post-traumatic stress disorder
14.5
11.6
19
13
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.3
11.5
60
191
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
16.2
11.5
18
11
P85
ICPC
Mental retardation
29.6
11.5
15
5
JDB10
NOMESCO Finland
Percutaneous gastrostomy
29.6
11.5
15
5
F50.9
ICD-10 Finland
Eating disorder, unspecified
29.6
11.5
15
5
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
11.5
105
472
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
63.9
11.5
13
*
P74
ICPC
Anxiety disorder/anxiety state
5.4
11.4
34
64
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
11.4
44
109
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
11.3
11
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
+∞
11.3
11
*
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
+∞
11.3
11
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
11.3
11
*
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
11.3
11
*
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
11.3
11
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.6
11.3
24
28
RT130
NOMESCO Finland
NA
117.9
11.3
12
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
11.2
171
964
WX722
NOMESCO Finland
PEEP
6.1
11.1
30
50
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
24.7
11.0
15
6
C07AA05
ATC
propranolol; systemic
3.0
10.9
66
232
F40.1
ICD-10 Finland
Social phobias
8.0
10.9
24
30
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.4
10.8
32
60
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.8
10.8
30
52
F40.2
ICD-10 Finland
Specific (isolated) phobias
42.6
10.8
13
*
C03CA01
ATC
furosemide; systemic
5.1
10.7
33
65
SPAT1240
SPAT
Therapeutic discussion
2.7
10.6
75
290
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
10.6
59
195
H35.1
ICD-10 Finland
Retinopathy of prematurity
27.6
10.6
14
5
SPAT1389
SPAT
Visit based on need for special support
2.8
10.5
71
266
TJD20
NOMESCO Finland
Change of gastrostomy tube
21.2
10.5
15
7
N06AB04
ATC
citalopram; systemic
5.8
10.5
29
50
RS312
NOMESCO Finland
NA
58.9
10.5
12
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
58.9
10.5
12
*
Z07
ICPC
Education problem
7.5
10.5
24
32
AA1AD
NOMESCO Finland
CT of head and brain
3.5
10.4
49
145
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.5
10.4
30
55
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
+∞
10.3
10
*
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
+∞
10.3
10
*
RT420
NOMESCO Finland
NA
+∞
10.3
10
*
F91.9
ICD-10 Finland
Conduct disorder, unspecified
+∞
10.3
10
*
F89
ICD-10 Finland
Unspecified disorder of psychological development
+∞
10.3
10
*
IEY01
NOMESCO Finland
Psychoeducation, individual
+∞
10.3
10
*
P98
ICPC
Psychosis NOS/other
+∞
10.3
10
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
+∞
10.3
10
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
107.9
10.3
11
*
R4140
NOMESCO Finland
Psychotherapy
107.9
10.3
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.4
10.2
50
152
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.1
10.2
39
96
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
32.0
10.2
13
*
H50.30
ICD-10 Finland
Intermittent esotropy
6.8
10.2
25
37
ZY000
NOMESCO Finland
Hospital inpatient
11.9
10.2
18
15
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.7
10.1
44
122
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
23.0
10.1
14
6
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
8.7
10.1
21
24
N03AX16
ATC
pregabalin; oral
4.2
10.0
38
93
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
12.9
10.0
17
13
R5140
NOMESCO Finland
Monitoring the use of the aid
6.2
9.9
26
42
P29
ICPC
Psychological sympt/compl other
3.4
9.9
47
140
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
9.8
115
577
E66.01
ICD-10 Finland
Obesity due to excess calories
3.7
9.8
42
115
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.8
9.7
27
47
J45.1
ICD-10 Finland
Nonallergic asthma
2.6
9.7
73
294
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
19.7
9.6
14
7
G47.3
ICD-10 Finland
Sleep apnoea
3.8
9.4
39
104
WX704
NOMESCO Finland
Intubation
4.2
9.3
35
85
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
9.0
9.3
19
21
H47.2
ICD-10 Finland
Optic atrophy
97.9
9.3
10
*
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
97.9
9.3
10
*
ZXY60
NOMESCO Finland
2-person team, nurses
97.9
9.3
10
*
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
97.9
9.3
10
*
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
97.9
9.3
10
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
9.3
9
*
F92.0
ICD-10 Finland
Depressive conduct disorder
+∞
9.3
9
*
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
+∞
9.3
9
*
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
+∞
9.3
9
*
N05AN01
ATC
lithium; oral
+∞
9.3
9
*
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
+∞
9.3
9
*
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
+∞
9.3
9
*
N03AE01
ATC
clonazepam; systemic
29.5
9.3
12
*
K92.0
ICD-10 Finland
Haematemesis
17.2
9.2
14
8
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
21.3
9.2
13
6
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
21.3
9.2
13
6
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
9.2
43
127
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
9.4
9.1
18
19
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
9.0
67
268
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
13.5
9.0
15
11
101
Kela drug reimbursment
Anterior pituitary hypofunction
5.4
9.0
26
48
H52.0
ICD-10 Finland
Hypermetropia
3.8
9.0
37
98
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.8
8.9
29
61
RF210
NOMESCO Finland
NA
7.6
8.9
20
26
RS311
NOMESCO Finland
NA
35.9
8.9
11
*
WX892
NOMESCO Finland
Monitored bed care
3.2
8.7
45
143
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
6.0
8.7
23
38
N88
ICPC
Epilepsy
12.3
8.7
15
12
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
48.9
8.6
10
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
48.9
8.6
10
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
48.9
8.6
10
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
3.6
8.5
38
108
SPAT1243
SPAT
Psychiatric/psychological examination
3.9
8.5
34
88
Z71.8
ICD-10 Finland
Other specified counselling
1.9
8.4
135
763
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.1
8.4
32
79
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
8.4
87
410
XF404
NOMESCO Finland
Ambulatory ECG
3.4
8.4
39
115
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
6.8
8.4
20
29
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
26.9
8.3
11
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.4
8.3
29
66
BF20A
NOMESCO Finland
NA
19.6
8.3
12
6
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
88.0
8.3
9
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
88.0
8.3
9
*
IGY02
SPAT
NA
88.0
8.3
9
*
F81.1
ICD-10 Finland
Specific spelling disorder
88.0
8.3
9
*
XCK00
NOMESCO Finland
Perimetry
6.3
8.3
21
33
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
8.3
99
500
T90
ICPC
Diabetes non-insulin dependent
5.1
8.3
25
49
K59.09
ICD-10 Finland
Constipation, unspecified
3.5
8.2
37
106
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
+∞
8.2
8
*
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
+∞
8.2
8
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
8.2
8
*
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
8.2
8
*
X78
ICD-10 Finland
Intentional self-harm by sharp object
+∞
8.2
8
*
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
+∞
8.2
8
*
IBA03
NOMESCO Finland
Psychotherapy evaluation
+∞
8.2
8
*
F84.0
ICD-10 Finland
Childhood autism
+∞
8.2
8
*
XA820
NOMESCO Finland
NA
+∞
8.2
8
*
N05AF03
ATC
chlorprothixene; systemic
+∞
8.2
8
*
ZXY49
NOMESCO Finland
Other health care provider
+∞
8.2
8
*
F20
ICD-10 Finland
Schizophrenia
+∞
8.2
8
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
3.7
8.2
35
96
P01
ICPC
Feeling anxious/nervous/tense
2.1
8.2
95
474
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
8.1
123
681
P99
ICPC
Psychological disorders other
9.3
8.1
16
17
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
5.8
8.1
22
38
N03AX11
ATC
topiramate; oral
7.0
8.1
19
27
IEP03
NOMESCO Finland
Focused parental counselling
7.0
8.1
19
27
R4190
NOMESCO Finland
Nutritional therapy
2.5
8.0
64
267
R06.5
ICD-10 Finland
Mouth breathing
2.8
8.0
50
180
XKD00
NOMESCO Finland
Uroflowmetry
4.2
8.0
29
69
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
7.4
8.0
18
24
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
8.0
40
125
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.1
8.0
24
47
N06BA09
ATC
atomoxetine; oral
32.6
8.0
10
*
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
5.3
7.9
23
43
E22.80
ICD-10 Finland
Central precocious puberty
16.8
7.9
12
7
N28
ICPC
Limited function/disability (N)
16.8
7.9
12
7
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.6
7.9
34
94
K07.24
ICD-10 Finland
Open bite
3.8
7.9
32
84
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
21.6
7.9
11
5
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.8
7.9
16
18
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.9
7.9
15
15
SPAT1262
SPAT
Handing over of treatment supplies
2.9
7.9
47
166
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.6
7.8
26
57
N03AF02
ATC
oxcarbazepine; oral
4.4
7.7
27
62
RS120
NOMESCO Finland
NA
12.8
7.7
13
10
ZX120
NOMESCO Finland
Intravenous
2.8
7.7
48
173
301
Kela drug reimbursment
Growth hormone
6.0
7.7
20
33
E66.8
ICD-10 Finland
Other obesity
6.0
7.7
20
33
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
8.3
7.6
16
19
ZX108
NOMESCO Finland
Inhalation
8.3
7.6
16
19
N06AX12
ATC
bupropion; oral
5.3
7.6
22
41
TAB00
NOMESCO Finland
Lumbar puncture
3.9
7.6
30
77
N29
ICPC
Neurological sympt/complt other
10.6
7.6
14
13
L28
ICPC
Limited function/disability (L)
3.3
7.6
37
113
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.3
7.6
27
63
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
14.7
7.6
12
8
C03DA01
ATC
spironolactone; oral
4.8
7.6
24
50
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.4
7.5
26
59
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.3
7.5
17
23
E34.31
ICD-10 Finland
Short stature, prenatal disorder
7.3
7.5
17
23
DFF20
NOMESCO Finland
Audiometry for children
5.2
7.5
22
42
RS140
NOMESCO Finland
NA
24.4
7.4
10
*
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
24.4
7.4
10
*
H03AA01
ATC
levothyroxine sodium; systemic
2.7
7.4
50
189
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
5.7
7.3
20
35
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
78.1
7.3
8
*
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
78.1
7.3
8
*
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
78.1
7.3
8
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
78.1
7.3
8
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.9
7.3
43
151
IER01
NOMESCO Finland
Psychoeducation, group
+∞
7.2
7
*
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
+∞
7.2
7
*
N05AE05
ATC
lurasidone; oral
+∞
7.2
7
*
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
+∞
7.2
7
*
AA400
NOMESCO Finland
Electroconvulsive therapy
+∞
7.2
7
*
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
7.2
7
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
+∞
7.2
7
*
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
+∞
7.2
7
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
7.2
7
*
ZXY03
NOMESCO Finland
Occupational therapist
+∞
7.2
7
*
RT121
NOMESCO Finland
NA
+∞
7.2
7
*
P07.3
ICD-10 Finland
Other preterm infants
3.2
7.2
36
113
SPAT1395
SPAT
Health check-up of persons outside student and working life
10.6
7.1
13
12
H50.2
ICD-10 Finland
Vertical strabismus
15.4
7.1
11
7
N05CF01
ATC
zopiclone; oral
3.5
7.1
32
93
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
7.1
126
737
RT190
NOMESCO Finland
NA
29.3
7.0
9
*
DFF00
NOMESCO Finland
Pure tone audiometry
3.4
7.0
33
99
A02BC02
ATC
pantoprazole; systemic
1.9
7.0
119
684
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
6.9
223
1554
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.3
6.9
24
55
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
11.8
6.9
12
10
G40.10
ICD-10 Finland
Simple partial seizures
11.8
6.9
12
10
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.0
6.9
21
42
A11CC03
ATC
alfacalcidol; systemic
5.9
6.9
18
30
RK220
NOMESCO Finland
NA
8.6
6.9
14
16
SPAT1281
SPAT
Other administrative function
2.4
6.8
59
256
ZX114
NOMESCO Finland
Intramuscular
6.2
6.8
17
27
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.8
6.8
27
71
G40.89
ICD-10 Finland
Other epilepsy
13.5
6.8
11
8
C07AB07
ATC
bisoprolol; oral
2.7
6.7
46
174
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.7
6.7
46
176
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.5
6.7
29
82
XG413
NOMESCO Finland
Spirometry with oscillometry
3.9
6.7
26
67
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
6.7
129
775
TLC00
NOMESCO Finland
Insertion of intrauterine device
4.7
6.7
21
44
N05AB03
ATC
perphenazine; systemic, rectal
38.9
6.7
8
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
9.1
6.6
13
14
XX4BW
NOMESCO Finland
NA
9.1
6.6
13
14
BC00A
NOMESCO Finland
NA
16.3
6.6
10
6
P24
ICPC
Specific learning problem
3.3
6.6
31
93
M79.6
ICD-10 Finland
Pain in limb
1.9
6.6
111
636
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
22.0
6.6
9
*
D09
ICPC
Nausea
2.3
6.5
59
260
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
4.0
6.5
24
59
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.8
6.5
26
69
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.7
6.5
14
18
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
5.8
6.4
17
29
Q38.1
ICD-10 Finland
Ankyloglossia
4.2
6.4
23
55
NF1DA
NOMESCO Finland
X-ray of hips
9.8
6.4
12
12
R51.80
ICD-10 Finland
Headache
2.0
6.4
89
477
F80.0
ICD-10 Finland
Specific speech articulation disorder
6.7
6.4
15
22
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
6.7
6.4
15
22
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.7
6.4
15
22
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
68.0
6.3
7
*
RS231
NOMESCO Finland
NA
68.0
6.3
7
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
68.0
6.3
7
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
68.0
6.3
7
*
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
68.0
6.3
7
*
RT120
NOMESCO Finland
NA
68.0
6.3
7
*
Z11
ICPC
Compliance/being ill problem
68.0
6.3
7
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
6.3
23
56
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
14.0
6.3
10
7
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
14.0
6.3
10
7
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.0
6.2
35
118
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
8.0
6.2
13
16
ZX121
NOMESCO Finland
Central venous catheter
8.0
6.2
13
16
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.0
6.2
13
16
N05AE04
ATC
ziprasidone; systemic
+∞
6.2
6
*
RT250
NOMESCO Finland
NA
+∞
6.2
6
*
RT320
NOMESCO Finland
NA
+∞
6.2
6
*
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
+∞
6.2
6
*
F21
ICD-10 Finland
Schizotypal disorder
+∞
6.2
6
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
+∞
6.2
6
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
+∞
6.2
6
*
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
+∞
6.2
6
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
6.2
6
*
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
+∞
6.2
6
*
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
+∞
6.2
6
*
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
+∞
6.2
6
*
RL720
NOMESCO Finland
NA
+∞
6.2
6
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
+∞
6.2
6
*
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
+∞
6.2
6
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
10.8
6.2
11
10
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
6.1
49
204
S03.22
ICD-10 Finland
Exarticulation of tooth
17.6
6.1
9
5
F41.8
ICD-10 Finland
Other specified anxiety disorders
5.4
6.1
17
31
RF430
NOMESCO Finland
NA
26.0
6.1
8
*
Z61.8
ICD-10 Finland
Other negative life events in childhood
26.0
6.1
8
*
R27.0
ICD-10 Finland
Ataxia, unspecified
26.0
6.1
8
*
Z61.7
ICD-10 Finland
Personal frightening experience in childhood
26.0
6.1
8
*
H02AB09
ATC
hydrocortisone; systemic
3.1
6.1
31
100
H81
ICPC
Excessive ear wax
2.6
6.0
42
161
F43.8
ICD-10 Finland
Other reactions to severe stress
6.2
6.0
15
24

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
328
1524
3.27
45.43
15.4
10.5
mmol/l
1.2
1.2
1.73
308
1416
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
317
1456
3.24
44.54
17.4
11.8
mmol/l
1.2
1.2
1.83
308
1388
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
276
1237
3.06
39.27
4.7
3.1
nmol/l
68.5
69.1
0.13
263
1181
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
376
2000
3.06
39.23
7.2
5.6
u/l
123.8
113.5
1.43
357
1880
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
647
3.19
33.47
3.1
3.0
mmol/l
2.4
2.4
1.48
160
578
(3014111) Lactate [Moles/volume] in Serum or Plasma
104
285
3.99
31.87
14.2
17.5
mmol/l
1.3
1.5
0.46
95
264
(3028707) Methadone [Presence] in Urine by Screen method
52
79
6.77
31.26
2.7
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
29
0
+∞
29.93
18.9
0.0
nmol/l
1332.7
—
—
29
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
29
0
+∞
29.93
14.6
0.0
nmol/l
18725.7
—
—
29
0
(3018418) pH of Serum or Plasma
154
576
3.07
28.89
4.4
4.2
ph
7.4
7.4
1.91
16
87
(3024561) Albumin [Mass/volume] in Serum or Plasma
222
1028
2.67
27.74
9.4
8.6
g/l
37.9
38.1
0.14
210
980
(40758558) Short blood count panel - Blood
250
1249
2.54
26.45
9.5
8.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
426
2736
2.60
25.89
4.5
3.0
pmol/l
14.6
14.5
0.35
396
2435
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
200
905
2.65
25.89
4.8
4.7
u/l
40.8
34.6
0.46
195
866
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
147
567
2.94
25.85
1.8
1.4
pmol/l
98.5
99.3
0.07
70
283
(3019550) Sodium [Moles/volume] in Serum or Plasma
506
3553
3.09
25.57
20.4
9.5
mmol/l
139.6
139.4
2.32
495
3413
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
241
1204
2.50
25.26
8.7
7.3
umol/l
21.3
20.7
0.08
226
1101
(3023103) Potassium [Moles/volume] in Serum or Plasma
505
3558
3.04
25.03
20.3
9.5
mmol/l
4.0
3.9
0.66
493
3399
(3003458) Phosphate [Moles/volume] in Serum or Plasma
161
663
2.79
24.98
13.7
10.1
mmol/l
1.3
1.4
0.71
153
630
(3044889) 12 lead EKG panel
260
1383
2.38
23.30
2.9
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
320
1891
2.29
22.08
10.7
6.7
mmol/l
5.9
6.2
2.45
304
1717
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
466
3237
2.57
22.06
5.0
3.2
mu/l
2.0
2.0
0.56
442
3025
(3012095) Magnesium [Moles/volume] in Serum or Plasma
114
425
2.92
21.00
15.4
12.2
mmol/l
0.8
0.8
0.49
108
407
(3000991) Gas panel - Venous blood
156
686
2.57
20.84
14.9
10.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
48
100
4.89
20.66
2.5
3.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
88
285
3.27
20.63
1.4
1.2
nmol/l
20.2
19.8
0.09
81
261
(3013115) Eosinophils [#/volume] in Blood
375
2417
2.24
20.30
11.3
8.9
e9/l
0.2
0.2
0.28
340
2059
(3006315) Basophils [#/volume] in Blood
366
2338
2.23
20.23
10.0
8.3
e9/l
0.0
0.0
0.14
324
1942
(3013650) Neutrophils [#/volume] in Blood by Automated count
389
2557
2.24
19.88
14.3
9.7
e9/l
3.6
3.5
0.54
343
2119
(3009508) Creatinine [Moles/volume] in Urine
170
794
2.44
19.87
4.2
4.8
mmol/l
7.9
8.7
0.87
150
748
(3002032) Base excess in Venous blood by calculation
163
747
2.48
19.85
8.6
9.5
mmol/l
0.8
1.1
0.75
132
591
(3001604) Monocytes [#/volume] in Blood
364
2336
2.20
19.66
10.0
8.3
e9/l
0.6
0.6
1.10
322
1940
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
365
2350
2.20
19.49
3.8
1.8
mmol/l
5.7
5.4
3.72
343
2156
(3049233) Organic acids panel - Urine
19
14
13.33
19.26
1.1
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
523
3971
2.78
18.28
11.7
7.3
u/l
32.8
27.1
2.18
511
3821
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
99
379
2.78
17.19
2.2
1.3
%
1.7
1.2
1.20
92
346
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
333
2146
2.06
16.75
4.5
2.9
mmol/mol
36.5
36.6
0.01
322
2037
(42870588) Differential panel, method unspecified - Blood
290
1778
2.06
16.72
9.3
9.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
368
2466
2.07
16.54
10.2
8.1
e9/l
2.3
2.3
0.10
335
2118
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
141
661
2.35
15.97
4.1
3.3
e6/l
4.5
1.6
2.14
86
367
(3019150) Specific gravity of Urine by Refractometry
150
727
2.28
15.70
3.2
2.7
kg/l
1.0
1.0
0.05
27
145
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
103
421
2.61
15.66
5.6
7.3
umol/l
6.0
6.6
0.17
89
346
(3010015) Selenium [Moles/volume] in Serum or Plasma
18
17
10.38
15.63
3.7
3.9
umol/l
1.2
1.0
0.90
18
17
(3013336) Amino acids [Identifier] in Serum or Plasma
22
28
7.74
15.33
3.4
2.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
336
2222
1.98
15.15
10.5
8.6
%
0.6
0.6
1.30
323
2116
(3009214) Lutropin [Units/volume] in Serum or Plasma
81
300
2.82
14.89
2.8
2.0
u/l
4.6
5.8
1.16
60
202
(3003396) Base excess in Arterial blood by calculation
61
192
3.26
14.87
19.6
14.5
mmol/l
-0.4
0.0
0.26
49
158
(4198724)
19
21
8.88
14.76
2.7
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
341
2280
1.97
14.74
10.5
8.5
%
3.1
3.3
0.83
328
2168
(3019069) Monocytes/100 leukocytes in Blood
341
2300
1.94
14.14
11.0
8.6
%
8.3
8.3
0.03
329
2193
(3013005) Retinol [Moles/volume] in Serum or Plasma
31
63
4.89
13.71
3.5
4.4
umol/l
1.7
1.8
0.20
31
63
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
15
14
10.46
13.07
4.6
2.2
umol/l
26.7
28.6
0.17
15
14
(3022948) Iron [Moles/volume] in Serum or Plasma
104
469
2.34
12.67
3.8
2.7
umol/l
12.9
14.3
1.11
95
452
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
143
739
2.10
12.47
17.3
7.7
kpa
5.0
5.0
0.10
138
713
(3018010) Neutrophils/100 leukocytes in Blood
346
2407
1.86
12.38
10.2
8.0
%
51.1
49.9
1.00
334
2301
(3004789) Transferrin [Mass/volume] in Serum or Plasma
97
430
2.37
12.27
3.8
2.7
g/l
2.6
2.5
0.24
86
415
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
142
736
2.10
12.27
17.3
7.7
mmol/l
0.4
0.9
1.25
105
533
(3022313) Gas panel - Capillary blood
133
673
2.13
12.23
15.7
7.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
564
2.21
12.15
1.8
1.9
mmol/l
1.6
1.2
2.67
108
518
(3017446) Testosterone [Moles/volume] in Serum or Plasma
79
320
2.56
12.13
2.6
1.8
nmol/l
9.5
12.0
1.16
65
276
(3011397) Hemoglobin [Presence] in Urine by Test strip
160
875
2.01
11.90
3.7
3.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
349
2453
1.83
11.88
10.5
8.2
%
34.0
35.0
0.90
337
2340
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
210
1261
1.90
11.86
5.9
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
40
111
3.61
11.83
1.8
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
370
2650
1.84
11.82
3.9
2.4
mmol/l
4.3
4.4
2.30
354
2528
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
669
2.11
11.72
4.2
3.2
e6/l
0.5
0.7
0.59
75
368
(3002385) Erythrocyte distribution width [Ratio]
514
4134
2.17
11.24
22.9
12.0
%
13.3
13.1
5.31
506
4054
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
364
2618
1.81
11.21
3.8
2.3
mmol/l
2.7
2.7
0.20
350
2474
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
351
2498
1.80
11.19
3.6
2.3
mmol/l
1.3
1.1
4.56
335
2386
(3011048) Pyruvate [Moles/volume] in Blood
12
10
11.66
11.16
1.4
1.5
umol/l
108.9
88.9
—
12
10
(3007853) Bacteria identified in Skin by Aerobe culture
99
464
2.24
10.95
2.1
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
314
2.46
10.72
14.1
5.9
ng/l
868.1
801.7
0.11
58
254
(3021589) Normoblasts [#/volume] in Blood
319
2228
1.77
10.64
10.2
9.6
e9/l
0.0
0.0
0.41
254
1690
(3044640) Blood type and Crossmatch panel - Blood
173
1008
1.89
10.52
3.6
3.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
69
281
2.51
10.45
2.9
2.0
iu/l
6.0
6.3
0.13
51
188
(3002582) Erythrocytes [#/volume] in Urine
194
1178
1.84
10.33
5.6
3.6
e6/l
11.1
32.8
2.20
152
885
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
405
2.25
10.14
4.2
2.8
%
19.7
23.4
1.89
83
383
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
358
2607
1.75
10.11
3.7
2.3
mmol/l
1.2
1.4
13.24
345
2476
(3035637) Corticotropin [Mass/volume] in Plasma
42
134
3.14
10.01
1.8
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
222
1415
1.78
10.00
6.7
4.2
e6/l
34.4
37.6
0.08
160
934
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
20
7.31
10.00
1.8
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
336
2418
1.72
9.76
8.9
5.3
ml/min/173m2
113.8
109.6
2.82
229
1663
(3011288) Drugs identified in Urine by Screen method
68
285
2.44
9.68
2.5
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
42
137
3.07
9.65
1.5
1.6
nmol/l
990.6
1027.3
0.09
32
101
(3026782) Osmolality of Urine
132
722
1.95
9.61
4.6
2.6
mosm/kgh2o
592.4
595.9
0.05
119
633
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
18
7.57
9.61
2.1
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
146
827
1.90
9.57
3.4
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
114
599
2.00
9.29
6.4
4.0
mg/l
1.2
1.7
0.59
85
404
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
89
429
2.15
9.12
5.1
3.0
ng/l
759.9
1562.8
1.00
56
243
(3026008) Bacteria identified in Urine by Culture
132
734
1.91
9.12
3.1
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
125
689
1.92
8.84
17.0
7.6
kpa
9.8
9.8
0.17
119
669
(3014007) Fractional oxyhemoglobin in Arterial blood
40
134
2.98
8.79
26.3
18.5
%
92.4
96.2
0.91
40
134
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
94
3.37
8.71
14.7
13.4
mmol/l
22.3
23.0
0.70
32
86
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
99
3.31
8.69
3.3
2.9
%
11.1
11.0
0.03
28
91
(3030467) Casts [#/volume] in Urine by Automated count
176
1090
1.76
8.52
5.7
3.4
e6/l
0.2
0.2
0.41
131
810
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
21
6.49
8.41
2.2
1.3
—
—
—
0
0
(3015736) pH of Urine
201
1299
1.71
8.32
3.8
2.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
60
256
2.37
8.21
2.1
2.7
u/l
23.0
37.8
3.51
49
213
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
39
134
2.90
8.20
26.8
18.5
%
0.6
0.7
1.61
39
134
(3019225) pH of Specimen
34
108
3.12
8.18
4.7
3.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
33
103
3.17
8.17
3.4
2.9
e9/l
1.7
1.5
0.35
23
62
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
297
2134
1.64
8.13
5.0
3.4
u/l
35.5
27.3
1.87
290
2052
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
52
209
2.50
8.09
2.4
2.5
mmol/l
2.4
2.4
0.04
40
173
(3018677) aPTT in Platelet poor plasma by Coagulation assay
108
585
1.93
8.00
9.1
6.1
s
31.0
30.8
0.08
108
577
(40761511) CBC panel - Blood by Automated count
525
4404
1.98
7.95
13.4
6.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
111
612
1.89
7.79
4.4
4.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
175
1115
1.70
7.52
5.7
3.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
306
2.19
7.44
2.4
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
31
99
3.09
7.40
3.2
2.7
e9/l
0.3
0.2
0.30
24
62
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
31
99
3.09
7.40
3.2
2.7
e6/l
657.8
527.2
0.49
24
60
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
121
2.87
7.30
26.7
18.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
155
2.63
7.23
4.7
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
67
3.52
7.07
26.0
25.7
u/ml
0.3
0.4
0.90
15
38
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
306
2.15
7.05
2.7
1.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
31
103
2.97
6.94
5.1
8.5
mmol/l
24.2
24.2
0.02
31
98
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
98
3.02
6.91
3.4
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
303
2252
1.56
6.76
5.4
3.2
e6/l
163.4
52.1
—
10
24
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
28
89
3.10
6.75
4.9
5.6
%
88.1
94.5
0.62
28
89
(3000850) Epithelial cells [#/volume] in Urine
127
764
1.74
6.63
4.6
2.8
e6/l
6.9
5.6
0.47
112
681
(3019060) Gas panel - Arterial blood
23
66
3.42
6.52
6.5
5.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
583
5165
2.68
6.49
25.0
12.1
e9/l
266.9
264.2
0.43
566
4918
(3032080) INR in Blood by Coagulation assay
128
779
1.72
6.40
9.2
3.7
inr
1.1
1.1
0.14
25
217
(3051611) Lipemic interference index of Serum or Plasma
20
53
3.69
6.36
2.9
4.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
583
5176
2.63
6.25
24.9
12.0
pg
29.0
29.1
0.89
577
5091
(3026361) Erythrocytes [#/volume] in Blood
583
5176
2.63
6.25
25.0
12.0
e12/l
4.7
4.7
0.95
562
4913
(3013512) EKG study
73
378
1.96
6.13
3.0
2.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
9
5
17.40
6.12
1.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
583
5183
2.60
6.09
25.0
12.1
e9/l
7.0
6.8
0.50
563
4930
(3024731) MCV [Entitic volume]
582
5175
2.54
5.98
25.0
12.0
fl
86.3
86.4
0.23
576
5089
(1001926) Buprenorphine [Presence] in Urine by Screen method
73
382
1.94
5.95
2.5
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
211
1485
1.54
5.78
5.4
4.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
137
872
1.64
5.74
3.8
3.5
mg/l
2.8
2.5
0.80
125
782
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
138
2.51
5.71
1.7
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
48
3.66
5.68
2.9
4.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
417
1.87
5.66
2.6
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
510
4357
1.71
5.65
16.0
8.6
mg/l
22.6
23.6
0.24
387
2953
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
13
27
4.67
5.61
2.2
1.7
nmol/l
20.8
20.0
—
5
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
49
3.58
5.52
1.0
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
20
5.33
5.47
8.4
7.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
48
222
2.15
5.47
2.3
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
28
4.50
5.38
5.2
3.0
—
—
—
0
0
(3020891) Body temperature
19
55
3.37
5.33
6.7
9.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
323
2520
1.47
5.21
5.1
3.9
mm/h
8.1
7.0
0.99
307
2331
(3005322) IgE [Units/volume] in Serum or Plasma
83
473
1.78
5.18
1.5
1.4
u/ml
228.5
403.3
0.86
77
449
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
127
2.48
5.17
2.5
4.4
e6/l
9.3
7.3
0.09
24
88
(3028026) IgM [Mass/volume] in Serum or Plasma
69
372
1.87
5.15
2.1
1.9
g/l
1.0
1.0
0.27
64
350
(3013931) Oligosaccharides [Presence] in Urine
5
0
+∞
5.12
1.0
0.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
27
99
2.68
5.10
3.4
2.9
e6/l
525.0
336.8
0.73
20
56
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
128
2.46
5.09
2.6
4.4
e6/l
35.9
90.2
0.46
26
91
(3027945) Reticulocytes/100 erythrocytes in Blood
85
491
1.76
5.07
7.2
6.4
%
1.5
1.3
0.55
79
468
(4034850)
19
57
3.25
5.06
14.4
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
90
529
1.73
5.05
3.1
2.0
ng/l
74.5
42.8
0.38
45
181
(3037467) Urinalysis macro (dipstick) panel - Urine
319
2493
1.46
5.04
5.7
3.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
68
3.02
4.95
2.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
130
2.42
4.93
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
71
2.89
4.61
2.1
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
71
2.89
4.61
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
141
2.30
4.56
3.2
3.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
31
129
2.36
4.55
2.3
4.1
mmol/l
3.3
3.4
0.55
31
122
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
18
56
3.13
4.54
4.2
5.1
umol/l
24.0
24.7
0.13
18
56
(3045424) Erythrocytes [Presence] in Urine
14
37
3.67
4.49
1.4
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
112
2.45
4.47
2.1
3.2
ml/min/173m2
85.2
97.5
—
7
31
(3035350) Ketones [Presence] in Urine by Test strip
233
1745
1.44
4.45
4.0
2.9
estimate
0.0
0.0
0.00
20
311
(3016244) Insulin [Units/volume] in Serum or Plasma
32
137
2.30
4.41
3.8
2.4
mu/l
14.5
14.9
0.08
32
127
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
8
9.65
4.39
1.8
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
213
1577
1.44
4.30
1.9
1.6
g/l
1.6
1.6
0.02
111
862
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
255
0.29
4.23
1.5
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
533
0.44
4.21
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
87
2.58
4.12
2.5
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
19
65
2.85
4.10
2.9
1.7
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
11
26
4.09
4.08
5.5
6.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
11
26
4.09
4.08
6.4
6.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
20
71
2.74
4.04
5.7
6.0
ug/l
2.6
1.9
0.49
20
71
(3021601) Nitrite [Presence] in Urine by Test strip
230
1744
1.41
4.01
5.7
4.3
estimate
0.0
0.0
0.00
25
329
(3001122) Ferritin [Mass/volume] in Serum or Plasma
243
1862
1.41
3.98
3.9
2.9
ug/l
65.0
64.2
0.03
235
1775
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
476
4904
0.67
3.98
3.7
3.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
176
2.07
3.97
1.5
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
245
0.30
3.95
1.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
56
2.95
3.92
4.8
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
60
339
1.76
3.87
1.5
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
14
6.21
3.85
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
206
1.96
3.80
5.9
9.2
g/l
0.2
0.4
1.29
26
161
(3023520) Reticulocytes [#/volume] in Blood
60
343
1.74
3.73
4.6
4.3
e9/l
73.6
60.5
1.39
47
188
(3003338) MCHC [Mass/volume]
509
4464
1.53
3.71
23.8
11.2
g/l
335.3
336.0
0.79
503
4407
(3009261) Glucose [Presence] in Urine by Test strip
229
1756
1.39
3.67
4.1
3.0
estimate
0.0
0.0
0.00
25
322
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
53
2.93
3.66
3.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
136
2.16
3.65
3.9
2.2
—
—
—
0
0
(4010399)
38
189
1.98
3.64
1.3
1.5
—
—
—
0
0
(44806118)
25
107
2.28
3.49
3.2
2.1
—
—
—
0
0
(44790047)
25
107
2.28
3.49
3.2
2.1
—
—
—
0
0
(44790049)
25
107
2.28
3.49
3.2
2.1
—
—
—
0
0
(44790048)
25
107
2.28
3.49
3.2
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
108
2.26
3.42
2.6
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
30
3.54
3.39
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
30
3.54
3.39
9.6
8.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
34
167
2.00
3.38
2.1
2.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
9
17
5.11
3.38
1.4
1.6
mu/l
651.3
292.2
—
9
17
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
98
2.29
3.25
2.7
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
225
1.84
3.25
2.0
2.1
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
9
18
4.83
3.24
1.4
1.6
%
72.7
74.4
—
9
18
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
343
1.68
3.21
1.6
1.3
iu/ml
137.8
154.1
0.09
12
121
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
93
2.30
3.17
2.2
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
93
2.30
3.17
3.2
1.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
14
47
2.89
3.15
17.2
9.3
mg/l
9.6
8.2
0.30
14
42
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
26
119
2.13
3.12
1.7
1.4
ug/l
5.8
8.0
0.41
26
114
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
132
2.07
3.12
3.5
2.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
19
4.57
3.11
27.1
8.0
mmol/l
1.2
1.2
—
9
14
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
15
5.14
3.07
3.4
4.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
122
863
1.44
3.04
3.7
3.0
estimate
0.0
0.0
0.50
25
309
(3024928) Oxygen saturation in Venous blood
22
95
2.25
3.03
5.0
22.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
83
2.34
3.01
1.5
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
122
2.08
2.94
2.8
4.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
16
4.82
2.93
1.8
2.1
—
—
—
0
0
(3032641) Amino acids panel - Urine
7
12
5.62
2.91
1.0
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
12
39
2.97
2.86
2.4
2.0
%
164.1
115.2
1.19
12
39
(4027681)
10
29
3.33
2.83
1.1
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
13
45
2.79
2.79
3.3
2.6
mmol/l
1.5
1.6
0.55
13
45
(3021901) Oxygen saturation in Capillary blood
16
62
2.50
2.79
7.1
9.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
9
6.41
2.77
2.7
3.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
78
1044
0.67
2.76
2.1
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
76
499
1.52
2.75
2.5
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
267
0.38
2.73
1.5
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
523
4682
1.46
2.72
22.7
11.1
%
40.1
40.2
0.03
459
4201
(3034426) Prothrombin time (PT)
8
18
4.28
2.68
1.4
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
23
3.77
2.65
3.1
5.3
ug/l
167.6
211.7
—
9
23
(3012516) Albumin [Mass/volume] in Urine
58
362
1.58
2.63
3.6
3.9
mg/l
1179.3
111.2
0.46
44
295
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
402
0.50
2.62
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
36
2.95
2.60
1.5
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
52
317
1.62
2.60
9.2
6.5
u/l
252.3
309.8
1.39
52
307
(3020682) Albumin/Creatinine [Ratio] in Urine
58
364
1.57
2.57
3.8
4.6
mg/mmol
4.9
9.2
0.64
40
295
(3023410) Appearance of Cerebral spinal fluid
21
96
2.13
2.56
3.1
5.1
—
—
—
0
0
(4306422)
15
59
2.46
2.55
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
45
266
1.66
2.53
1.6
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
42
2.76
2.53
1.5
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
84
2.20
2.51
2.8
4.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
37
2.87
2.48
2.5
4.8
ug/l
18.2
25.0
1.23
11
37
(3017509) Phencyclidine [Presence] in Urine
5
7
6.86
2.47
1.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
49
2.56
2.40
4.5
5.2
—
—
—
0
0
(3002256) Pathology report gross observation
43
255
1.66
2.40
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
38
2.79
2.38
2.2
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
16
4.21
2.37
2.0
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
210
1678
1.30
2.35
1.5
1.8
u/ml
0.4
3.5
7.15
39
308
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
74
2.23
2.34
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
33
2.92
2.33
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
170
1.78
2.29
3.2
1.8
%
30.3
33.2
0.66
21
126
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
17
75
2.20
2.27
3.9
1.9
mmol/l
1.5
2.2
—
10
59
(3000764) Benzodiazepines [Presence] in Urine
78
537
1.44
2.25
2.5
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
45
2.58
2.25
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
115
848
1.36
2.24
5.7
4.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
55
353
1.53
2.23
2.8
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
318
0.50
2.20
1.7
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
79
548
1.43
2.20
2.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
79
548
1.43
2.20
2.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
123
1.90
2.19
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
123
1.90
2.19
1.4
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
46
2.52
2.16
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
187
2110
0.78
2.16
2.0
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
90
2.05
2.15
2.7
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
39
233
1.64
2.14
7.6
5.0
%
0.8
0.6
0.30
13
66
(4146454)
5
9
5.33
2.14
2.6
3.4
—
—
—
0
0
(4035726)
32
182
1.72
2.10
2.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
65
2.23
2.10
2.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
110
1328
0.74
2.09
1.8
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
41
2.59
2.09
1.5
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
53
2.37
2.07
3.1
2.8
%
17.5
18.4
—
7
28
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
14
4.12
2.06
2.3
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
78
549
1.41
2.01
2.5
1.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
10
4.80
1.99
4.2
3.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
10
4.80
1.99
1.0
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
506
0.62
1.99
1.5
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
15
3.84
1.95
1.2
1.0
—
—
—
0
0
(4268621)
12
49
2.36
1.92
2.7
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
225
1.61
1.91
2.6
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
117
886
1.32
1.91
1.9
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
26
2.96
1.91
2.0
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
32
2.71
1.89
1.0
1.2
mg/l
262.9
268.7
—
9
26
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
300
0.53
1.87
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
56
2.24
1.86
8.1
6.5
mmol/l
1.5
2.4
—
6
29
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
44
2.41
1.83
3.2
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
44
2.41
1.83
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
27
2.85
1.83
2.0
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
27
2.85
1.83
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
686
1.35
1.82
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
77
2.01
1.76
3.6
2.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
28
2.75
1.76
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
39
2.47
1.76
1.1
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
10
39
2.47
1.76
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
80
985
0.74
1.73
1.8
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
498
0.65
1.70
1.4
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
29
2.65
1.69
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
46
2.31
1.68
3.1
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
219
1.56
1.64
2.8
1.9
—
92.7
—
0
19
(3002179) Metamyelocytes/100 leukocytes in Blood
34
213
1.55
1.59
5.3
4.7
%
0.7
0.3
—
10
45
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
74
1.96
1.56
1.7
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
305
0.58
1.54
6.8
2.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
138
1559
0.80
1.52
2.4
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
82
1.88
1.51
2.4
1.8
iu/l
2.4
6.5
—
6
31
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
20
2.88
1.50
1.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
20
2.88
1.50
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
20
2.88
1.50
1.3
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
155
1258
1.24
1.45
3.4
2.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
20
112
1.73
1.44
1.6
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
382
1.38
1.40
2.7
2.6
u/l
7591.8
4837.7
0.19
13
159
(3021440) Promyelocytes/100 leukocytes in Blood
34
221
1.50
1.37
7.8
5.0
%
0.1
0.0
0.24
12
62
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
71
1.90
1.37
1.6
1.4
u/ml
9.0
1.9
—
8
31
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
169
1.55
1.30
1.4
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
17
2.82
1.29
1.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
80
1.81
1.28
3.1
1.6
—
—
—
0
0
(4062490)
14
74
1.82
1.23
1.6
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
35
2.20
1.22
3.6
2.3
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
18
2.66
1.22
1.4
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
18
2.66
1.22
1.2
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
75
1.80
1.18
1.1
1.1
—
—
—
0
0
(4094501)
0
34
0.00
1.15
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
159
1.52
1.14
1.5
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
38
2.02
1.12
3.4
1.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
7
29
2.32
1.12
1.1
8.2
—
153.8
—
0
20
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
77
1.75
1.10
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
173
1460
1.18
1.07
1.6
1.7
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
31
2.17
1.07
1.3
1.7
umol/l
7.1
9.3
—
7
31
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
31
2.17
1.07
2.1
1.2
%
79.7
89.2
—
7
31
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
31
2.17
1.07
5.3
6.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
93
1.66
1.05
2.8
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
32
219
1.42
1.04
8.1
5.1
%
0.0
0.1
0.74
11
55
(3022670) pH of Venous cord blood
5
21
2.28
1.03
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
746
1.22
0.99
1.7
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
27
2.13
0.91
1.0
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
193
1.40
0.90
2.4
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
28
2.05
0.88
2.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
171
0.61
0.86
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
171
0.61
0.86
1.4
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
34
245
1.34
0.85
1.1
1.2
—
14.5
—
0
7
(3021879) Hepatitis B virus core Ab [Presence] in Serum
56
435
1.25
0.82
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
45
1.71
0.80
1.8
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
31
1.85
0.80
5.8
6.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
63
1.68
0.78
3.1
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
191
1.36
0.77
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
188
0.65
0.76
1.0
1.1
—
8.1
—
0
32
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
22
2.18
0.76
1.0
1.8
—
—
—
0
0
(1002224) Polysomnography panel
14
87
1.55
0.75
1.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
35
260
1.30
0.73
1.9
2.2
—
11.2
—
0
23
(3037522) Nuclear Ab [Titer] in Serum
65
522
1.21
0.72
1.4
1.6
titre
980.0
541.4
—
8
88
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
135
1428
0.87
0.69
2.7
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
129
1.42
0.69
1.2
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
19
129
1.42
0.69
1.4
2.1
—
59.2
—
0
13
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
222
1.30
0.66
1.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
42
1.60
0.65
2.1
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
28
1.71
0.63
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
234
0.73
0.63
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
67
548
1.19
0.62
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
18
125
1.39
0.59
1.3
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
295
1.24
0.59
2.7
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
61
1.57
0.58
1.4
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
22
0.00
0.58
0.0
4.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
33
1.74
0.58
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
33
1.74
0.58
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
8
51
1.50
0.58
6.0
4.6
%
1.0
0.9
—
8
39
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
34
1.69
0.57
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
128
1340
0.89
0.56
2.4
2.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
35
1.64
0.56
1.3
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
37
289
1.24
0.55
2.8
1.8
u/ml
165.2
150.1
0.13
20
138
(3004588) Protein electrophoresis panel - Serum or Plasma
6
36
1.60
0.55
1.0
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
217
0.74
0.54
2.1
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
58
1.49
0.54
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
79
1.46
0.52
3.2
4.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
182
0.73
0.51
1.9
1.5
iu/ml
0.0
0.1
—
7
49
(21494434) Karyotype in Bone marrow
7
43
1.56
0.49
1.4
1.3
—
—
—
0
0
(44813793)
11
73
1.45
0.47
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
111
0.68
0.46
1.3
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
47
1.43
0.46
1.3
1.8
mmol/l
8.4
6.6
—
7
35
(3020961) Endomysium IgA Ab [Titer] in Serum
61
511
1.15
0.45
1.2
1.4
—
229.3
—
0
21
(3011648) Oxygen content in Venous blood
11
74
1.43
0.44
6.7
25.9
%
14.0
11.6
1.58
11
74
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
30
1.60
0.42
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
30
1.60
0.42
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
30
1.60
0.42
1.0
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
90
0.63
0.42
1.7
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
31
1.54
0.42
2.8
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
32
1.49
0.41
1.0
1.1
miu/ml
2497.4
1823.7
—
5
32
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
32
1.49
0.41
1.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
32
1.49
0.41
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
195
1.23
0.40
1.3
1.3
—
—
—
0
0
(4211845)
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
33
1.45
0.40
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
33
1.45
0.40
2.4
3.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
18
0.00
0.39
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
298
0.83
0.39
1.4
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
35
1.37
0.37
1.4
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
326
0.84
0.36
1.4
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
74
0.64
0.36
4.6
3.5
e9/l
2.4
3.1
—
5
74
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
41
1.40
0.35
14.5
6.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
43
1.33
0.34
1.3
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
126
0.75
0.32
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
125
0.76
0.31
1.7
1.8
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
21
167
1.21
0.30
1.0
1.0
mu/l
10.2
9.5
0.19
15
135
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
80
1.32
0.30
1.9
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
559
0.90
0.29
2.5
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
239
1.17
0.29
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
54
1.24
0.29
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
62
1.23
0.27
1.3
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
99
1.26
0.27
1.5
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
108
1.24
0.26
5.2
2.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
397
1.11
0.25
1.5
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
11
83
1.27
0.24
2.7
3.0
g/l
134.2
135.4
0.07
11
69
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
242
0.86
0.23
1.5
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.5
—
9.3
—
0
11
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
95
956
0.94
0.20
3.5
2.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
211
1.14
0.20
1.1
1.1
u/ml
4.1
9.9
0.93
12
133
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
48
1.19
0.19
1.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
49
1.17
0.19
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
177
0.86
0.19
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
89
806
1.06
0.18
2.5
2.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
305
0.90
0.17
1.2
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
63
0.76
0.17
1.6
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
63
0.76
0.17
1.8
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
98
893
1.06
0.17
3.4
3.7
ug/g
88.9
125.6
1.01
78
721
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
65
0.73
0.17
9.0
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
67
1.14
0.16
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
303
0.91
0.15
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
75
0.76
0.15
7.7
3.7
%
42.8
49.2
—
6
75
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
6
75
0.76
0.15
1.3
1.9
mmol/l
8.3
6.9
—
6
47
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
76
0.75
0.15
1.2
1.6
—
290.0
—
0
5
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
226
1.10
0.14
1.2
1.1
u/ml
3.7
9.4
1.46
14
136
(40768443) Skin Pathology biopsy report
11
89
1.18
0.14
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
95
0.80
0.13
1.1
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
136
1.13
0.12
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
38
340
1.07
0.12
1.7
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
180
0.90
0.11
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
687
1.05
0.11
2.1
2.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
18
155
1.11
0.11
1.2
1.5
u/ml
2.1
3.6
0.48
12
108
(3021788) Differential panel - Synovial fluid
5
44
1.09
0.09
1.6
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
167
0.91
0.08
1.4
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
157
0.91
0.08
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
56
1.02
0.08
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
56
1.02
0.08
1.5
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
58
0.82
0.08
1.0
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
68
0.84
0.07
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
185
0.93
0.07
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
46
422
1.04
0.07
1.2
1.3
u/ml
3.4
1.9
0.33
28
277
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
96
0.89
0.06
1.0
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
97
0.88
0.06
1.7
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
155
0.92
0.06
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
263
1.05
0.06
1.5
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
134
0.92
0.05
1.6
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
423
0.97
0.04
1.2
1.2
iu/ml
13.8
16.6
—
8
100
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
1149
0.99
0.03
1.9
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
373
1.02
0.02
1.1
1.2
u/ml
3.9
4.7
0.11
14
125
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
131
0.95
0.02
1.6
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
15
150
0.95
0.01
1.3
1.5
u/ml
27.2
11.3
—
10
103
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
206
0.97
0.00
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
206
0.97
0.00
1.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
27
263
0.98
0.00
1.7
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
159
1.02
0.00
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
269
0.99
0.00
1.4
1.3
miu/ml
330.1
252.2
0.39
11
141
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
127
0.98
0.00
1.6
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
12
115
1.00
0.00
1.2
1.4
u/ml
52.4
15.7
—
7
95
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
172
1.00
0.00
3.2
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
41
391
1.00
0.00
1.1
1.2
u/ml
1.7
1.2
0.22
27
289
(3006598) pH of Arterial cord blood
13
128
0.97
0.00
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
13
128
0.97
0.00
1.0
1.0
kpa
6.7
7.3
—
7
100
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
397
1.01
0.00
1.2
1.2
u/ml
0.9
8.8
1.90
14
121
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
204
0.98
0.00
1.5
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
41
396
0.99
0.00
1.1
1.2
u/ml
4.6
7.8
0.77
27
309
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
205
0.98
0.00
1.5
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
123
1.01
0.00
1.1
1.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
13
126
0.98
0.00
1.0
1.0
kpa
3.5
3.4
—
7
98
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
198
1.01
0.00
1.0
1.1
u/ml
0.9
0.4
—
9
91
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
17.4
—
0
5
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
8.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
47
1.02
0.00
1.4
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.6
—
1435.4
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
9
89
0.96
0.00
1.0
2.0
u/l
41.0
39.0
—
9
84
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
58
0.99
0.00
1.0
1.5
—
1.3
—
0
5
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.0
—
2.1
—
0
7
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
53
0.90
0.00
3.2
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
71
0.94
0.00
1.0
1.4
—
10.8
—
0
7
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
72
0.93
0.00
1.0
1.4
—
40.7
—
0
9
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
52
0.92
0.00
1.0
1.0
g/l
175.6
163.1
—
5
52
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
48
0.99
0.00
1.4
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017958) Strawberry IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.3
—
0.9
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_MOTOR_EXMORE and mortality.

Females

Parameter HR [95% CI] p-value
KRA_PSY_MOTOR_EXMORE 5.423 [3.53, 8.32] < 0.001
Birth year 0.999 [0.99, 1.01] 0.718

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 4619 females with KRA_PSY_MOTOR_EXMORE died.

Males

Parameter HR [95% CI] p-value
KRA_PSY_MOTOR_EXMORE 1.391 [1.09, 1.78] 0.009
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 74 out of 12381 males with KRA_PSY_MOTOR_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_MOTOR_EXMORE.

N-year risk Females Males
1 0.535% 0.22%
5 3.684% 1.348%
10 8.492% 3.597%
15 15.025% 6.466%
20 25.122% 10.711%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_MOTOR_EXMORE – Motor disorders, excluding more controls

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data